Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Hiring now
4
+2 posted in 30 days
Backers
1
Longitude Capital
Momentum
20/100
hiring for its size
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Apriori BioFounded 2020
Protecting against viral threats. Ushering in a new era of AI-enabled vaccine design.
Atavistik BioSeries B $120M · 9 mo ago • Founded 2021 • 51-200 employees • 1 role
Atavistik Bio is a clinical stage biotechnology company developing novel allosteric therapeutics. Our approach enables selective modulation…
Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates with the aim to reduce harmful inflammation and…
Windward BioSeries A $200M · 20 mo ago • 51-200 employees
Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological…
LassenVenture round $85M · 2 yr ago
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
Sequence Bio11-50 employees
We study the genetic causes of inherited disease to push drug discovery forward with the right targets and predictors of drug response from…

Overview

Innovative therapeutics that target serious viral and liver diseases Assembly Bio is applying our passion, scientific ingenuity and deep knowledge of virology and liver diseases to pursue novel therapies with the potential to change the paradigm for the treatment of serious diseases.

News

News YahooFinance 4 years ago
Assembly Bio Announces Retirement of John G. McHutchison, AO, MD as CEO and Appoints Current President and COO Jason A. Okazaki as Successor
Dr. McHutchison will continue to provide strategic counsel as board member and chairman of the Science & Technology Committee of the boardSOUTH SAN FRANCISCO, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-
Read more
Report
News YahooFinance 5 years ago
Assembly Bio Selects Fourth HBV Core Inhibitor Candidate for Advancement Into Clinical Development
SOUTH SAN FRANCISCO, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today announced it has selected a fourth
Read more
Report
News WRAL.com 20 years ago
Raleigh, NC Breaking News, Weather, Traffic - WRAL NBC affiliate
Get the latest Raleigh area news, weather forecasts, I-40 traffic, ACC and high school sports, strange news and blogs for Central and Eastern North Carolina, including Raleigh, Durham, Cary, Chapel Hill, Fayetteville, Rocky Mount and Wilson.
Read more
Report

Salary insights

Compensation ranges based on this company's open jobs
Median
$147k
Typical range
$91k – $234k
Open positions
4
4 Jobs
Junior 50%
Senior 25%
Architect 25%
Level Jobs Median Typical range
Junior 2 $91k $91k
Senior 1 $204k $204k
Architect 1 $234k $234k
Highest paying role Director, Medicinal Chemistry $234k
Normalized to USD per year

Growth

Hiring Momentum
28/100
Slowing
Open positions
4
0 opened / 0 closed in 30 days
ATS activity
Every ~4 hours
Today
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
75% ▼
Industrial Engineering
25% ▲

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
South San Francisco
South San Francisco United States
HQ
Contact Us
4 open roles 4 posted in 90 days 75% engineering $155k Avg Salary
hires for Science & Research, Industrial Engineering
7th floor, South San Francisco, CA 94080
seen since Aug 2026 company site, job postings